Project description
Research in detecting novel infectious diseases
Climate change and more frequent environmental disasters are creating larger and increasingly dangerous breeding grounds for new diseases and infections. This has made the development of improved methods and solutions for detecting and preventing outbreaks of current and new diseases critical. With the support of the Marie Skłodowska-Curie Actions programme, the VERPI project aims to develop a research programme that addresses emerging infectious diseases through a one-health approach. Specifically, it will unite partners from Europe, Asia, Africa, and North America, strengthening current pathogen discovery and characterisation solutions, increasing efficiency in developing countermeasures, and enhancing biomarker discovery for both long-term health impacts and viral pathogenesis. It will utilise transparent health communication to improve public trust.
Objective
"The Global Viral Ecosystem Research and Preparedness Initiative (VERPI) is a comprehensive research programme addressing emerging infectious diseases through a One Health approach. VERPI project unites ten partners from eight countries across four continents — Europe, Asia, Africa, Northern America— to strengthen global research capacity for equitable pandemic preparedness.
The VERPI scientific programme is structured around four main objectives 1. Strengthening capacity for pathogen discovery and characterisation 2. Accelerating countermeasures development: broad-spectrum antivirals, monoclonal antibodies and diagnostics 3. Enhancing biomarker discovery for viral pathogenesis and long-term health impacts 4. Leveraging community engagement to enhance public trust through transparent health communication.
VERPI's innovative ""triple I"" —interdisciplinary, international, and intersectoral—framework leverages diverse expertise, transcends national boundaries, and bridges academic and clinical sectors. Central to VERPI's strategy are embedded secondments, fostering interdisciplinary collaboration and a dynamic approach to translational research in emerging viral epidemics. This promotes a broad R&I platform for rapid response to future viral threats, supporting EU Sustainable Development Goals to strengthen early warning systems and health risk management capacities globally."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antivirals
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2024-SE-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
4 DUBLIN
Ireland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.